Posted by LLS Health Technical Team | 05/03/2022

Apisolex™ technology provides formulators with a safe, polyamino-acid-based excipient to enhance the solubility of BCS Class II and IV APIs, including oncology agents, for parenteral delivery.

Categories: Pharmaceuticals, News

Posted by LLS Health Technical Team | 01/11/2022

Lubrizol Life Science Health is committed to providing a single-source solution that supports customers from concept to commercialization for their medical device solutions. The recent expansion of our U.S. Medical Device Design Center represents the next phase of this commitment.

Categories: Medical Devices, News